BioAge Bets Its $350 Million War Chest on ‘Inflammaging’ as New Mouse Research Shows Exercise Can Switch Off the Heart’s Inflammatory Aging Program
BioAge says it has more than $350 million to test whether an upstream NLRP3 inflammation blocker can treat age-related disease, while a new mouse study finds exercise reverses about 95% of age-linked gene changes in the heart. Here is why inflammaging is becoming a business thesis.
Read more